Form 8-K - Current report:
SEC Accession No. 0001140361-25-026864
Filing Date
2025-07-23
Accepted
2025-07-23 09:27:56
Documents
14
Period of Report
2025-07-23
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20052364_8k.htm   iXBRL 8-K 56131
2 EXHIBIT 3.1 ef20052364_ex3-1.htm EX-3.1 47790
3 EXHIBIT 3.2 ef20052364_ex3-2.htm EX-3.2 251944
  Complete submission text file 0001140361-25-026864.txt   555774

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA elev-20250723.xsd EX-101.SCH 3892
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elev-20250723_lab.xml EX-101.LAB 23415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elev-20250723_pre.xml EX-101.PRE 17078
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20052364_8k_htm.xml XML 4548
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 251141851
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)